文献速递痛风与晶体性关节病

改善痛风住院患者结局:一项系统综述

Improving outcomes for patients hospitalized with gout: a systematic review.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

多数研究为单中心小样本回顾性分析,存在偏倚风险;尚无研究前瞻性评估预防痛风发作住院患者再入院的策略。

要点

  • 多数研究为单中心小样本回顾性分析,存在偏倚风险。
  • 已知有效药物(别嘌醇、泼尼松龙、NSAIDs、阿那白滞素)改善住院痛风患者结局。
  • 住院风湿科会诊和医院痛风管理方案与结局改善相关。

核心结论

  • 迫切需要高质量前瞻性研究,以提高住院患者对降尿酸治疗的接受度,并纳入发作预防和血清尿酸达标治疗优化。

研究设计与样本

  • 系统综述,检索MEDLINE、Embase和Cochrane图书馆从建库至2021年4月8日,使用「gout」和「hospital」及其同义词,纳入评估痛风发作住院或急诊就诊期间干预措施有效性和/或实施情况的研究,并进行偏倚风险评估。

主要发现

  • 8项研究报告了非药物干预(住院风湿科会诊和医院痛风管理方案)与结局改善相关。
  • 尚无研究前瞻性评估旨在预防痛风发作住院患者再入院的策略。

临床怎么用

  • 住院痛风患者可考虑使用已知有效的药物(别嘌醇、泼尼松龙、NSAIDs、阿那白滞素)以改善结局。
  • 住院风湿科会诊和医院痛风管理方案可能改善住院痛风患者结局。
  • 需关注降尿酸治疗的接受度、发作预防和血清尿酸达标治疗优化。

局限性

  • 多数研究为小样本、单中心回顾性分析,存在偏倚风险。
  • 尚无前瞻性研究评估预防痛风发作住院患者再入院的策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Hospital admissions for gout flares have increased dramatically in recent years, despite widely available, effective medications for the treatment and prevention of flares. We conducted a systematic review to evaluate the effectiveness and implementation of interventions in patients hospitalized for gout flares. METHODS: A search was conducted in MEDLINE, Embase and the Cochrane library, from database inception to 8 April 2021, using the terms 'gout' and 'hospital' and their synonyms. Studies were included if they evaluated the effectiveness and/or implementation of interventions during hospital admissions or emergency department attendances for gout flares. Risk of bias assessments were performed for included studies. RESULTS: Nineteen articles were included. Most studies were small, retrospective analyses performed in single centres, with concerns for bias. Eleven studies (including five randomized controlled trials) reported improved patient outcomes following pharmacological interventions with known efficacy in gout, including allopurinol, prednisolone, NSAIDs and anakinra. Eight studies reported improved outcomes associated with non-pharmacological interventions: inpatient rheumatology consultation and a hospital gout management protocol. No studies to date have prospectively evaluated strategies designed to prevent re-admissions of patients hospitalized for gout flares. CONCLUSION: There is an urgent need for high-quality, prospective studies of strategies for improving uptake of urate-lowering therapies in hospitalized patients, incorporating prophylaxis against flares and treat-to-target optimization of serum urate levels. Such studies are essential if the epidemic of hospital admissions from this treatable condition is to be countered.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Russell MD, Clarke BD, Roddy E, et al. Improving outcomes for patients hospitalized with gout: a systematic review. Rheumatology (Oxford). 2021. PMID: 34247233. doi:10.1093/rheumatology/keab539

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。